Medpace Holdings, Inc.
Company Stats
- Market Cap
- $17.4B
- as of Sep 30, 2026
- Shares Outstanding
- 27.9M
- Free Float
- 59.3%
Income Statement
- Revenue
- $2.5B
- Operating Income
- $534.9M
- Net Income
- $451.1M
- EBITDA
- $562.1M
- Revenue Growth, 3Y
- 20.1%
- FCF Margin, 3Y Avg
- 25.0%
- FCF Margin, Worst Year
- 21.0%
Cash Flow
- Free Cash Flow
- $681.9M
- FCF Yield
- 3.9%
- Owner FCF Yield
- 3.7%
Balance Sheet
- Cash & Equivalents
- $497.0M
Returns & Capital
- Share Repurchases
- $917.4M
- Buyback Yield, 3Y Avg
- 2.4%
- SBC, 3Y Avg
- $26.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.5B | $681.9M | 26.9% |
| FY2024 | $2.1B | $572.3M | 27.1% |
| FY2023 | $1.9B | $396.7M | 21.0% |
| FY2022 | $1.5B | $351.2M | 24.1% |
| FY2021 | $1.1B | $235.1M | 20.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges